Can Inflammatory Hematological Parameters be a Guide to Late-onset Fetal Growth Restriction?


Journal

Zeitschrift fur Geburtshilfe und Neonatologie
ISSN: 1439-1651
Titre abrégé: Z Geburtshilfe Neonatol
Pays: Germany
ID NLM: 9508901

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 27 6 2020
medline: 9 1 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

To compare the rates obtained from hematological parameters in cases of late-onset idiopathic fetal growth restriction (FGR) with healthy pregnancies and to evaluate the effect on neonatal outcomes. The study group consisted of 63 pregnant women with late-onset idiopathic FGR and the control group consisted of 91 healthy pregnant women. The determined rates were calculated from the control hemograms of patients at 28 weeks. Both groups were compared for neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and other parameters. NLR, leukocyte and neutrophil levels were significantly higher in the FGR group (p<0.05). There was no significant difference in PLR, platelet and lymphocyte levels between the groups (p>0.05). To predict FGR, the best cut-off value of NLR was determined to be 4.11 with 56% sensitivity and 88% specificity values. Neutrophil, lymphocyte and platelet interactions have an important role in FGR development. Inflammation can be involved in the etiopathogenesis in late-onset FGR.

Identifiants

pubmed: 32590874
doi: 10.1055/a-1177-1516
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

262-268

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest

Auteurs

Demet Aydogan Kırmızı (DA)

Department of Obstetrics and Gynecology, Yozgat Bozok Universty, Medicine of Faculty, Yozgat, Turkey.

Emre Baser (E)

Department of Obstetrics and Gynecology, Yozgat Bozok Universty, Medicine of Faculty, Yozgat, Turkey.

Taylan Onat (T)

Department of Obstetrics and Gynecology, Yozgat Bozok Universty, Medicine of Faculty, Yozgat, Turkey.

Melike Demir Caltekin (MD)

Department of Obstetrics and Gynecology, Yozgat Bozok Universty, Medicine of Faculty, Yozgat, Turkey.

Mustafa Kara (M)

Department of Obstetrics and Gynecology, Yozgat Bozok Universty, Medicine of Faculty, Yozgat, Turkey.

Ethem Serdar Yalvac (ES)

Department of Obstetrics and Gynecology, Yozgat Bozok Universty, Medicine of Faculty, Yozgat, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH